TY - JOUR
T1 - Correction
T2 - Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)
AU - Elnaggar, Muhammad
AU - Agte, Sarita
AU - Restrepo, Paula
AU - Ram, Meghana
AU - Melnekoff, David
AU - Adamopoulos, Christos
AU - Stevens, Mark M.
AU - Kappes, Katerina
AU - Leshchenko, Violetta
AU - Verina, Daniel
AU - Jagannath, Sundar
AU - Poulikakos, Poulikos I.
AU - Parekh, Samir
AU - Laganà, Alessandro
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - The authors of the original article [1] mistakenly omitted a Funding source which is stated ahead: Alessandro Lagana was supported by the ASH Bridge Grant Award.
AB - The authors of the original article [1] mistakenly omitted a Funding source which is stated ahead: Alessandro Lagana was supported by the ASH Bridge Grant Award.
UR - http://www.scopus.com/inward/record.url?scp=85158106496&partnerID=8YFLogxK
U2 - 10.1186/s13045-023-01449-x
DO - 10.1186/s13045-023-01449-x
M3 - Comment/debate
AN - SCOPUS:85158106496
SN - 1756-8722
VL - 16
JO - Journal of Hematology and Oncology
JF - Journal of Hematology and Oncology
IS - 1
M1 - 52
ER -